U-19451A: a selective inducible nitric oxide synthase inhibitor

Area of Science:

• Pharmacology
• Neuroscience
• Immunology

Background:

• Inducible nitric oxide synthase (iNOS) inhibition is a promising therapeutic strategy for neurodegenerative disorders, chronic inflammatory diseases, and septic shock.
• Developing drugs with high selectivity for iNOS over neuronal nitric oxide synthase (nNOS) is crucial to minimize potential side effects.

Purpose of the Study:

• To investigate the selectivity of U-19451A, a potential nitric oxide synthase (NOS) inhibitor, for iNOS inhibition.
• To compare the selectivity of U-19451A with established inhibitors S-methylthiourea (SMT) for iNOS and L-nitroarginine methyl ester (L-NAME) for nNOS.

Main Methods:

• Assessed iNOS activity in rat lungs and glial cell cultures stimulated with E. coli lipopolysaccharide and gamma-interferon.
• Evaluated nNOS activity in rat cerebellum and primary cerebellar granule cell cultures.
• Determined selectivity of U-19451A, SMT, and L-NAME using these experimental models.

Main Results:

• U-19451A demonstrated 4-times greater selectivity for iNOS inhibition compared to nNOS in tissues, similar to SMT.
• In cell cultures, U-19451A exhibited superior selectivity for iNOS inhibition compared to SMT.
• L-NAME showed high selectivity (16-31 times) for inhibiting nNOS activity.

Conclusions:

• U-19451A displays significant selectivity for iNOS inhibition.
• This selectivity profile suggests U-19451A could be an effective therapeutic agent for inflammatory conditions.
• The drug's specificity may reduce adverse effects associated with nNOS inhibition.